SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
15.14
-0.56 (-3.57%)
At close: Sep 15, 2025, 4:00 PM EDT
15.44
+0.30 (1.98%)
After-hours: Sep 15, 2025, 4:12 PM EDT
SI-BONE Revenue
SI-BONE had revenue of $48.63M in the quarter ending June 30, 2025, with 21.67% growth. This brings the company's revenue in the last twelve months to $185.26M, up 22.93% year-over-year. In the year 2024, SI-BONE had annual revenue of $167.18M with 20.37% growth.
Revenue (ttm)
$185.26M
Revenue Growth
+22.93%
P/S Ratio
3.58
Revenue / Employee
$530,837
Employees
349
Market Cap
653.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 167.18M | 28.29M | 20.37% |
Dec 31, 2023 | 138.89M | 32.48M | 30.52% |
Dec 31, 2022 | 106.41M | 16.26M | 18.03% |
Dec 31, 2021 | 90.15M | 16.77M | 22.84% |
Dec 31, 2020 | 73.39M | 6.09M | 9.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SIBN News
- 6 days ago - SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 20 days ago - SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025 - GlobeNewsWire
- 5 weeks ago - SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance - GlobeNewsWire
- 6 weeks ago - SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 - GlobeNewsWire
- 2 months ago - SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 - GlobeNewsWire
- 3 months ago - SI-BONE to Truist Securities MedTech Conference on June 17, 2025 - GlobeNewsWire
- 3 months ago - SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025 - GlobeNewsWire